Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Epstein-Barr virus reactivation during pregnancy and postpartum: effects of race and racial discrimination.

Christian LM, Iams JD, Porter K, Glaser R.

Brain Behav Immun. 2012 Nov;26(8):1280-7. doi: 10.1016/j.bbi.2012.08.006. Epub 2012 Aug 25.

2.

Prevalence of Epstein-Barr virus reactivation in pregnancy.

Haeri S, Baker AM, Boggess KA.

Am J Perinatol. 2010 Oct;27(9):715-9. doi: 10.1055/s-0030-1253098. Epub 2010 Apr 12.

PMID:
20387188
3.

Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype.

Parks CG, Cooper GS, Hudson LL, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Pandey JP.

Arthritis Rheum. 2005 Apr;52(4):1148-59.

5.

Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.

Farrell RA, Antony D, Wall GR, Clark DA, Fisniku L, Swanton J, Khaleeli Z, Schmierer K, Miller DH, Giovannoni G.

Neurology. 2009 Jul 7;73(1):32-8. doi: 10.1212/WNL.0b013e3181aa29fe. Epub 2009 May 20.

6.
7.

Maternal depression and Epstein-Barr virus reactivation in early pregnancy.

Haeri S, Johnson N, Baker AM, Stuebe AM, Raines C, Barrow DA, Boggess KA.

Obstet Gynecol. 2011 Apr;117(4):862-6. doi: 10.1097/AOG.0b013e31820f3a30.

PMID:
21422857
8.

Racial-ethnic differences in Epstein-Barr virus antibody titers among U.S. children and adolescents.

Ford JL, Stowe RP.

Ann Epidemiol. 2013 May;23(5):275-80. doi: 10.1016/j.annepidem.2013.02.008.

PMID:
23621993
9.

Maternal depressive symptoms related to Epstein-Barr virus reactivation in late pregnancy.

Zhu P, Chen YJ, Hao JH, Ge JF, Huang K, Tao RX, Jiang XM, Tao FB.

Sci Rep. 2013 Oct 31;3:3096. doi: 10.1038/srep03096.

10.

Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.

Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX.

Cancer. 2004 Mar 15;100(6):1162-70.

11.

Race/ethnic and socioeconomic differences in stress and immune function in The National Longitudinal Study of Adolescent Health.

Dowd JB, Palermo T, Chyu L, Adam E, McDade TW.

Soc Sci Med. 2014 Aug;115:49-55. doi: 10.1016/j.socscimed.2014.06.011. Epub 2014 Jun 10.

PMID:
24946263
12.

Epstein-Barr virus infection during pregnancy and the risk of adverse pregnancy outcome.

Eskild A, Bruu AL, Stray-Pedersen B, Jenum P.

BJOG. 2005 Dec;112(12):1620-4.

13.

Attachment anxiety is related to Epstein-Barr virus latency.

Fagundes CP, Jaremka LM, Glaser R, Alfano CM, Povoski SP, Lipari AM, Agnese DM, Yee LD, Carson WE 3rd, Farrar WB, Malarkey WB, Chen M, Kiecolt-Glaser JK.

Brain Behav Immun. 2014 Oct;41:232-8. doi: 10.1016/j.bbi.2014.04.002. Epub 2014 Jun 16.

14.
15.

Autonomic and glucocorticoid associations with the steady-state expression of latent Epstein-Barr virus.

Cacioppo JT, Kiecolt-Glaser JK, Malarkey WB, Laskowski BF, Rozlog LA, Poehlmann KM, Burleson MH, Glaser R.

Horm Behav. 2002 Aug;42(1):32-41.

PMID:
12191645
17.

Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan.

Shinkura R, Yamamoto N, Koriyama C, Shinmura Y, Eizuru Y, Tokunaga M.

J Med Virol. 2000 Apr;60(4):411-6.

PMID:
10686024
18.

Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.

Robertson P, Beynon S, Whybin R, Brennan C, Vollmer-Conna U, Hickie I, Lloyd A.

J Med Virol. 2003 Aug;70(4):617-23.

PMID:
12794726
20.

Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation.

Luderer R, Kok M, Niesters HG, Schuurman R, de Weerdt O, Thijsen SF.

Mol Diagn. 2005;9(4):195-200.

PMID:
16392898

Supplemental Content

Support Center